D

Delcath Systems
D

DCTH

8.21000
USD
-0.43
(-4.98%)
مغلق
حجم التداول
6,188
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
305,489,197
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.10000
    (-2.04%)
    4.80000 USD
    A
    AEZS
    0.14000
    (2.41%)
    5.94000 USD
    A
    ARDX
    -0.02500
    (-0.45%)
    5.52500 USD
    B
    BLPH
    0
    (0%)
    0.000000 USD
    C
    CAPR
    -0.17000
    (-4.19%)
    3.89000 USD
    C
    CDTX
    -0.190
    (-1.45%)
    12.890 USD
    C
    CLRB
    -0.10000
    (-4.65%)
    2.05000 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    X
    XENE
    0.630
    (1.46%)
    43.790 USD
الأخبار
المقالات

العنوان: Delcath Systems

القطاع: Healthcare
الصناعة: Medical Devices
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.